NG101m Adjuvant Therapy in Glioblastoma Patients

Inclusion Criteria

• •Male or female subjects ≥ 18 years of age
• •Must be newly diagnosed with GBM
• •Primary treatment must consist of a chemoradiation therapy (CRT) regimen
• •Hemoglobin \> 9 g/dL
• •White blood count 3,600 - 11,000/mm3
• •Absolute neutrophil count (ANC) ≥ 1,500/mm3
• •Absolute lymphocyte count (ALC) ≥ 1,000/mm3
• •Platelet count 100,000/mm3
• •BUN ≤ 1.5 times upper limit of normal
• •Creatinine clearance rate \> 40 mL/min
• •ALT ≤ 3 times upper limit of normal
• •AST ≤ 3 times upper limit of normal
• •Alkaline phosphatase ≤ 3 times upper limit of normal
• •Total bilirubin ≤ 2.0 mg/dL
• •Karnofsky Performance Status ≥ 70
• •Must not be on any other alternative therapies
• •Not pregnant